4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-000862
Options or other derivatives
- Chief Executive Officer acquired 5,236 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Finley John David Chief Executive Officer | 2023-01-03 | Grant or award · Restricted Stock Units | +5,236 | 5,236 | D | ||
Loading xslF345X03/ownership.xml…